Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants

Inclusion Criteria: General criteria: * Male or female older than 50, * Provide written informed consent, * Patient affiliated to French social security, * Maximum sampling volume (care + research) per 30-day period to be adapted according to the weight of the patient Specific criteria: Patient presenting in both eyes: * Either the same type of AMD defined according to the modified international AREDS study (Ferris et al. 2013), * or early AMD in one eye and atrophic AMD in the other eye, the patient will therefore be defined as being atrophic * or early AMD in one eye and exudative AMD in the other eye, the patient will therefore be defined as exudative, * or no retinal pathology (control group). Exclusion Criteria: General criteria: * Patient whose weight is less than 50kg, * Adult patient under guardianship or curatorship or unable to express consent, * Person deprived of liberty, * Patient participating in an ongoing clinical trial during the inclusion visit, Specific criteria: * Patient with atrophic AMD in one eye and exudative AMD in the other eye, * Patient presenting with chronic retinal pathologies other than AMD, defined according to the modified international AREDS study (Ferris et al. 2013) , in the included eye, * Patient taking systemic drugs with an immunomodulatory action: immunosuppressants, immunomodulators, chemotherapy or corticosteroids, * Patient with systemic pathologies modifying their immune status, * Patient with a history of diabetes, * Patient who had dynamic phototherapy on the included eye.